HB 1281-FN (2020): requiring insurance coverage for epinephrine auto-injectors.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1281-FN (2020): requiring insurance coverage for epinephrine auto-injectors.” Granite Record, https://graniterecord.org/bill/2020/hb1281. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1281-FN (2020): requiring insurance coverage for epinephrine auto-injectors. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1281
- Chicago
- Granite Record. “HB 1281-FN (2020): requiring insurance coverage for epinephrine auto-injectors.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1281.
- BibTeX
@misc{bill-2020-hb1281, title = {HB 1281-FN (2020): requiring insurance coverage for epinephrine auto-injectors.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1281}, note = {Accessed 24 Oct. 2026} }
HB 1281-FN (2020)
requiring insurance coverage for epinephrine auto-injectors.
- Status: Died on the table
- Term: 2019-2020
- House committee: Commerce and Consumer Affairs
- Senate committee: Commerce
- Subject: Insurance
The Story
It was introduced on January 8, 2020 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 21, 2020. The committee held a work session on January 30, 2020. The committee met in executive session on February 4, 2020 to vote on its recommendation. The minority of the committee recommended that the House kill it. The majority of the committee recommended that the House pass it with changes (amendment 2020-0455h) by a vote of 15–5, and the report was placed on the regular calendar. The committee's amendment (2020-0455h) was adopted on a voice vote on February 19, 2020, changing the text of the bill. On February 19, 2020 the House voted to pass it with changes on a roll call 208–110. It crossed to the Senate on March 11, 2020 and was referred to the Senate Commerce committee. On June 16, 2020 the Senate adopted “Vacated from Committee and Laid on Table” on a voice vote. The bill died on the table under Senate Rule 3-23 at adjournment on September 16, 2020, having been set aside and never taken back up.
Sponsors
Hearings and Sessions
- January 21, 2020, 10:30 AM: public hearing, House Commerce and Consumer Affairs, LOB 302
- January 30, 2020, 1:00 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- February 4, 2020, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302
Votes
- February 19, 2020, House: Ought to Pass with Amendment — yeas 208, nays 110, passed
- June 16, 2020, Senate: Vacated from Committee and Laid on Table — voice vote, passed
The Docket
- January 8, 2020: Introduced 01/08/2020 and referred to Commerce and Consumer Affairs
- January 21, 2020: Public Hearing: 01/21/2020 10:30 am LOB 302
- January 30, 2020: Subcommittee Work Session: 01/30/2020 01:00 pm LOB 302
- February 4, 2020: Executive Session: 02/04/2020 10:00 am LOB 302
- February 12, 2020: Minority Committee Report: Inexpedient to Legislate
- February 19, 2020: Majority Committee Report: Ought to Pass with Amendment #2020-0455h (NT) for 02/19/2020 (Vote 15-5; RC)
- February 19, 2020: Amendment #2020-0455h (NT): AA VV 02/19/2020
- February 19, 2020: Ought to Pass with Amendment 2020-0455h (NT): MA RC 208-110 02/19/2020
- March 11, 2020: Introduced 03/11/2020 and Referred to Commerce
- June 16, 2020: Vacated from Committee and Laid on Table, MA, VV; 06/16/2020
- September 16, 2020: Inexpedient to Legislate, Senate Rule 3-23, Adjournment 09/16/2020